Bellevue Group’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,600
| Closed | -$118K | – | 158 |
|
|
2024
Q4 | $118K | Hold |
13,600
| – | – | ﹤0.01% | 151 |
|
|
2024
Q3 | $266K | Buy |
13,600
+3,600
| +36% | +$70.3K | ﹤0.01% | 140 |
|
|
2024
Q2 | $206K | Buy |
+10,000
| New | +$206K | ﹤0.01% | 145 |
|
|
2022
Q3 | – | Sell |
-63,700
| Closed | -$1.17M | – | 180 |
|
|
2022
Q2 | $1.17M | Sell |
63,700
-2,280
| -3% | -$41.8K | 0.02% | 136 |
|
|
2022
Q1 | $1.06M | Buy |
+65,980
| New | +$1.06M | 0.01% | 149 |
|
|
2021
Q4 | – | Sell |
-57,500
| Closed | -$1.08M | – | 208 |
|
|
2021
Q3 | $1.08M | Sell |
57,500
-500
| -0.9% | -$9.37K | 0.01% | 156 |
|
|
2021
Q2 | $1.21M | Hold |
58,000
| – | – | 0.01% | 148 |
|
|
2021
Q1 | $1.64M | Hold |
58,000
| – | – | 0.02% | 148 |
|
|
2020
Q4 | $1.89M | Buy |
58,000
+10,000
| +21% | +$327K | 0.02% | 146 |
|
|
2020
Q3 | $1.47M | Buy |
+48,000
| New | +$1.47M | 0.02% | 149 |
|
|
2020
Q2 | – | Sell |
-57,100
| Closed | -$568K | – | 214 |
|
|
2020
Q1 | $568K | Sell |
57,100
-100,700
| -64% | -$1M | 0.01% | 154 |
|
|
2019
Q4 | $2.17M | Sell |
157,800
-8,500
| -5% | -$117K | 0.03% | 128 |
|
|
2019
Q3 | $2.52M | Buy |
166,300
+21,100
| +15% | +$320K | 0.05% | 125 |
|
|
2019
Q2 | $2.86M | Buy |
145,200
+115,900
| +396% | +$2.28M | 0.05% | 120 |
|
|
2019
Q1 | $486K | Buy |
+29,300
| New | +$486K | 0.03% | 133 |
|